1h Free Analyst Time
The publisher has been monitoring the non-Hodgkin lymphoma therapeutics market and is forecast to grow by $5427.51 mn during 2022-2027, accelerating at a CAGR of 8.14% during the forecast period. Our report on the non-Hodgkin lymphoma therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by recent approvals and strong pipeline, growing geriatric population, and special drug designations.
The publisher's non-Hodgkin lymphoma therapeutics market is segmented as below:
By Distribution Channel
- Hospital pharmacy
- Retail pharmacy
- Online pharmacy
- Others
By Therapy
- Immunotherapy
- Targeted therapy
- Chemotherapy
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the non-Hodgkin lymphoma therapeutics market covers the following areas:
- Non-Hodgkin lymphoma therapeutics market sizing
- Non-Hodgkin lymphoma therapeutics market forecast
- Non-Hodgkin lymphoma therapeutics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary1.1 Market overview
- Exhibit 01: Executive Summary - Chart on Market Overview
- Exhibit 02: Executive Summary - Data Table on Market Overview
- Exhibit 03: Executive Summary - Chart on Global Market Characteristics
- Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
- Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
- Exhibit 06: Executive Summary - Chart on Market Segmentation by Therapy
- Exhibit 07: Executive Summary - Chart on Incremental Growth
- Exhibit 08: Executive Summary - Data Table on Incremental Growth
- Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- Exhibit 13: Market segments
3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4.1 Global non-hodgkin lymphoma therapeutics market 2017 - 2021
- Exhibit 18: Historic Market Size - Data Table on Global non-hodgkin lymphoma therapeutics market 2017 - 2021 ($ million)
- Exhibit 19: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
- Exhibit 20: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ million)
- Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
- Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
- Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
- Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
- Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
- Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
- Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6.1 Market segments
- Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
- Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
- Exhibit 32: Chart on Comparison by Distribution Channel
- Exhibit 33: Data Table on Comparison by Distribution Channel
- Exhibit 34: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
- Exhibit 38: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
- Exhibit 42: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million)
- Exhibit 43: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million)
- Exhibit 44: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
- Exhibit 45: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
- Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
- Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
- Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
- Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
- Exhibit 50: Market opportunity by Distribution Channel ($ million)
7.1 Market segments
- Exhibit 51: Chart on Therapy - Market share 2022-2027 (%)
- Exhibit 52: Data Table on Therapy - Market share 2022-2027 (%)
- Exhibit 53: Chart on Comparison by Therapy
- Exhibit 54: Data Table on Comparison by Therapy
- Exhibit 55: Chart on Immunotherapy - Market size and forecast 2022-2027 ($ million)
- Exhibit 56: Data Table on Immunotherapy - Market size and forecast 2022-2027 ($ million)
- Exhibit 57: Chart on Immunotherapy - Year-over-year growth 2022-2027 (%)
- Exhibit 58: Data Table on Immunotherapy - Year-over-year growth 2022-2027 (%)
- Exhibit 59: Chart on Targeted therapy - Market size and forecast 2022-2027 ($ million)
- Exhibit 60: Data Table on Targeted therapy - Market size and forecast 2022-2027 ($ million)
- Exhibit 61: Chart on Targeted therapy - Year-over-year growth 2022-2027 (%)
- Exhibit 62: Data Table on Targeted therapy - Year-over-year growth 2022-2027 (%)
- Exhibit 63: Chart on Chemotherapy - Market size and forecast 2022-2027 ($ million)
- Exhibit 64: Data Table on Chemotherapy - Market size and forecast 2022-2027 ($ million)
- Exhibit 65: Chart on Chemotherapy - Year-over-year growth 2022-2027 (%)
- Exhibit 66: Data Table on Chemotherapy - Year-over-year growth 2022-2027 (%)
- Exhibit 67: Market opportunity by Therapy ($ million)
8.1 Customer landscape overview
- Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9.1 Geographic segmentation
- Exhibit 69: Chart on Market share By Geographical Landscape 2022-2027 (%)
- Exhibit 70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
- Exhibit 71: Chart on Geographic comparison
- Exhibit 72: Data Table on Geographic comparison
- Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
- Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
- Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
- Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 101: Chart on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 102: Data Table on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 103: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 104: Data Table on China - Year-over-year growth 2022-2027 (%)
- Exhibit 105: Chart on Canada - Market size and forecast 2022-2027 ($ million)
- Exhibit 106: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
- Exhibit 107: Chart on Canada - Year-over-year growth 2022-2027 (%)
- Exhibit 108: Data Table on Canada - Year-over-year growth 2022-2027 (%)
- Exhibit 109: Market opportunity By Geographical Landscape ($ million)
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
- Exhibit 110: Impact of drivers and challenges in 2022 and 2027
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
- Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
- Exhibit 112: Overview on factors of disruption
- Exhibit 113: Impact of key risks on business
12.1 Vendors covered
- Exhibit 114: Vendors covered
- Exhibit 115: Matrix on vendor position and classification
- Exhibit 116: AstraZeneca Plc - Overview
- Exhibit 117: AstraZeneca Plc - Product/Service
- Exhibit 118: AstraZeneca Plc - Key news
- Exhibit 119: AstraZeneca Plc - Key offerings
- Exhibit 120: BeiGene Ltd. - Overview
- Exhibit 121: BeiGene Ltd. - Business segments
- Exhibit 122: BeiGene Ltd. - Key offerings
- Exhibit 123: BeiGene Ltd. - Segment focus
- Exhibit 124: Biogen Inc. - Overview
- Exhibit 125: Biogen Inc. - Product/Service
- Exhibit 126: Biogen Inc. - Key offerings
- Exhibit 127: Bristol Myers Squibb Co. - Overview
- Exhibit 128: Bristol Myers Squibb Co. - Product/Service
- Exhibit 129: Bristol Myers Squibb Co. - Key news
- Exhibit 130: Bristol Myers Squibb Co. - Key offerings
- Exhibit 131: Eisai Co. Ltd. - Overview
- Exhibit 132: Eisai Co. Ltd. - Business segments
- Exhibit 133: Eisai Co. Ltd. - Key offerings
- Exhibit 134: Eisai Co. Ltd. - Segment focus
- Exhibit 135: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 136: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 137: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 138: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 139: F. Hoffmann La Roche Ltd. - Segment focus
- Exhibit 140: Gilead Sciences Inc. - Overview
- Exhibit 141: Gilead Sciences Inc. - Product/Service
- Exhibit 142: Gilead Sciences Inc. - Key news
- Exhibit 143: Gilead Sciences Inc. - Key offerings
- Exhibit 144: GlaxoSmithKline Plc - Overview
- Exhibit 145: GlaxoSmithKline Plc - Business segments
- Exhibit 146: GlaxoSmithKline Plc - Key offerings
- Exhibit 147: GlaxoSmithKline Plc - Segment focus
- Exhibit 148: Johnson and Johnson Services Inc. - Overview
- Exhibit 149: Johnson and Johnson Services Inc. - Business segments
- Exhibit 150: Johnson and Johnson Services Inc. - Key news
- Exhibit 151: Johnson and Johnson Services Inc. - Key offerings
- Exhibit 152: Johnson and Johnson Services Inc. - Segment focus
- Exhibit 153: Merck KGaA - Overview
- Exhibit 154: Merck KGaA - Business segments
- Exhibit 155: Merck KGaA - Key news
- Exhibit 156: Merck KGaA - Key offerings
- Exhibit 157: Merck KGaA - Segment focus
- Exhibit 158: Novartis AG - Overview
- Exhibit 159: Novartis AG - Business segments
- Exhibit 160: Novartis AG - Key offerings
- Exhibit 161: Novartis AG - Segment focus
- Exhibit 162: Pfizer Inc. - Overview
- Exhibit 163: Pfizer Inc. - Product/Service
- Exhibit 164: Pfizer Inc. - Key news
- Exhibit 165: Pfizer Inc. - Key offerings
- Exhibit 166: Seagen Inc. - Overview
- Exhibit 167: Seagen Inc. - Product/Service
- Exhibit 168: Seagen Inc. - Key offerings
- Exhibit 169: Spectrum Pharmaceuticals Inc. - Overview
- Exhibit 170: Spectrum Pharmaceuticals Inc. - Product/Service
- Exhibit 171: Spectrum Pharmaceuticals Inc. - Key offerings
- Exhibit 172: Teva Pharmaceutical Industries Ltd. - Overview
- Exhibit 173: Teva Pharmaceutical Industries Ltd. - Business segments
- Exhibit 174: Teva Pharmaceutical Industries Ltd. - Key news
- Exhibit 175: Teva Pharmaceutical Industries Ltd. - Key offerings
- Exhibit 176: Teva Pharmaceutical Industries Ltd. - Segment focus
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
- Exhibit 177: Inclusions checklist
- Exhibit 178: Exclusions checklist
- Exhibit 179: Currency conversion rates for US$
- Exhibit 180: Research methodology
- Exhibit 181: Validation techniques employed for market sizing
- Exhibit 182: Information sources
- Exhibit 183: List of abbreviations
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 6: Executive Summary - Chart on Market Segmentation by Therapy
Exhibit 7: Executive Summary - Chart on Incremental Growth
Exhibit 8: Executive Summary - Data Table on Incremental Growth
Exhibit 9: Executive Summary - Chart on Vendor Market Positioning
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
Exhibit 12: Offerings of vendors included in the market definition
Exhibit 13: Market segments
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 18: Historic Market Size - Data Table on Global non-hodgkin lymphoma therapeutics market 2017 - 2021 ($ million)
Exhibit 19: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
Exhibit 20: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ million)
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibit 32: Chart on Comparison by Distribution Channel
Exhibit 33: Data Table on Comparison by Distribution Channel
Exhibit 34: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 38: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 42: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibit 50: Market opportunity by Distribution Channel ($ million)
Exhibit 51: Chart on Therapy - Market share 2022-2027 (%)
Exhibit 52: Data Table on Therapy - Market share 2022-2027 (%)
Exhibit 53: Chart on Comparison by Therapy
Exhibit 54: Data Table on Comparison by Therapy
Exhibit 55: Chart on Immunotherapy - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Immunotherapy - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Immunotherapy - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Immunotherapy - Year-over-year growth 2022-2027 (%)
Exhibit 59: Chart on Targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Data Table on Targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Chart on Targeted therapy - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on Targeted therapy - Year-over-year growth 2022-2027 (%)
Exhibit 63: Chart on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on Chemotherapy - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on Chemotherapy - Year-over-year growth 2022-2027 (%)
Exhibit 67: Market opportunity by Therapy ($ million)
Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 69: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 71: Chart on Geographic comparison
Exhibit 72: Data Table on Geographic comparison
Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 101: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 103: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibit 105: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 106: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 107: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 108: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 109: Market opportunity By Geographical Landscape ($ million)
Exhibit 110: Impact of drivers and challenges in 2022 and 2027
Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
Exhibit 112: Overview on factors of disruption
Exhibit 113: Impact of key risks on business
Exhibit 114: Vendors covered
Exhibit 115: Matrix on vendor position and classification
Exhibit 116: AstraZeneca Plc - Overview
Exhibit 117: AstraZeneca Plc - Product/Service
Exhibit 118: AstraZeneca Plc - Key news
Exhibit 119: AstraZeneca Plc - Key offerings
Exhibit 120: BeiGene Ltd. - Overview
Exhibit 121: BeiGene Ltd. - Business segments
Exhibit 122: BeiGene Ltd. - Key offerings
Exhibit 123: BeiGene Ltd. - Segment focus
Exhibit 124: Biogen Inc. - Overview
Exhibit 125: Biogen Inc. - Product/Service
Exhibit 126: Biogen Inc. - Key offerings
Exhibit 127: Bristol Myers Squibb Co. - Overview
Exhibit 128: Bristol Myers Squibb Co. - Product/Service
Exhibit 129: Bristol Myers Squibb Co. - Key news
Exhibit 130: Bristol Myers Squibb Co. - Key offerings
Exhibit 131: Eisai Co. Ltd. - Overview
Exhibit 132: Eisai Co. Ltd. - Business segments
Exhibit 133: Eisai Co. Ltd. - Key offerings
Exhibit 134: Eisai Co. Ltd. - Segment focus
Exhibit 135: F. Hoffmann La Roche Ltd. - Overview
Exhibit 136: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 137: F. Hoffmann La Roche Ltd. - Key news
Exhibit 138: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 139: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 140: Gilead Sciences Inc. - Overview
Exhibit 141: Gilead Sciences Inc. - Product/Service
Exhibit 142: Gilead Sciences Inc. - Key news
Exhibit 143: Gilead Sciences Inc. - Key offerings
Exhibit 144: GlaxoSmithKline Plc - Overview
Exhibit 145: GlaxoSmithKline Plc - Business segments
Exhibit 146: GlaxoSmithKline Plc - Key offerings
Exhibit 147: GlaxoSmithKline Plc - Segment focus
Exhibit 148: Johnson and Johnson Services Inc. - Overview
Exhibit 149: Johnson and Johnson Services Inc. - Business segments
Exhibit 150: Johnson and Johnson Services Inc. - Key news
Exhibit 151: Johnson and Johnson Services Inc. - Key offerings
Exhibit 152: Johnson and Johnson Services Inc. - Segment focus
Exhibit 153: Merck KGaA - Overview
Exhibit 154: Merck KGaA - Business segments
Exhibit 155: Merck KGaA - Key news
Exhibit 156: Merck KGaA - Key offerings
Exhibit 157: Merck KGaA - Segment focus
Exhibit 158: Novartis AG - Overview
Exhibit 159: Novartis AG - Business segments
Exhibit 160: Novartis AG - Key offerings
Exhibit 161: Novartis AG - Segment focus
Exhibit 162: Pfizer Inc. - Overview
Exhibit 163: Pfizer Inc. - Product/Service
Exhibit 164: Pfizer Inc. - Key news
Exhibit 165: Pfizer Inc. - Key offerings
Exhibit 166: Seagen Inc. - Overview
Exhibit 167: Seagen Inc. - Product/Service
Exhibit 168: Seagen Inc. - Key offerings
Exhibit 169: Spectrum Pharmaceuticals Inc. - Overview
Exhibit 170: Spectrum Pharmaceuticals Inc. - Product/Service
Exhibit 171: Spectrum Pharmaceuticals Inc. - Key offerings
Exhibit 172: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 173: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 174: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 175: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 176: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibit 177: Inclusions checklist
Exhibit 178: Exclusions checklist
Exhibit 179: Currency conversion rates for US$
Exhibit 180: Research methodology
Exhibit 181: Validation techniques employed for market sizing
Exhibit 182: Information sources
Exhibit 183: List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global non-Hodgkin lymphoma therapeutics market: AstraZeneca Plc, Baxter International Inc., Bayer AG, BeiGene Ltd., Biogen Inc., Bristol Myers Squibb Co., Eisai Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck KGaA, Novartis AG, Pfizer Inc., Seagen Inc., Spectrum Pharmaceuticals Inc., Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd.Commenting on the report, an analyst from the researcher said: 'The latest trend gaining momentum in the market is research grants and funding.'
According to the report, one of the major drivers for this market is the recent approvals and strong pipeline.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AstraZeneca Plc
- Baxter International Inc.
- Bayer AG
- BeiGene Ltd.
- Biogen Inc.
- Bristol Myers Squibb Co.
- Eisai Co. Ltd.
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- Gilead Sciences Inc.
- GlaxoSmithKline Plc
- Johnson and Johnson Services Inc.
- Merck KGaA
- Novartis AG
- Pfizer Inc.
- Seagen Inc.
- Spectrum Pharmaceuticals Inc.
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
